The recently published STEP trial showed a dramatic effect on weight loss with the weekly injectable semaglutide versus placebo. Lay media picked up the headlines from this potential "GameChanger" medication for weight loss. With this one shot will patient lose themselves?
Reference: Wilding J, Batterham R, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. February 10, 2021. DOI: 10.1056/NEJMoa2032183
CPE details for GameChangers Podcast March 2021
Learning Objective: Discuss the design of the STEP trial
0107-0000-21-097-H01-P
0.25 CEU/2.5 Hrs (Knowledge)
Initial Release Date: 03/02/21
Expiration Date: 03/02/24
Additional CPE information is located at https://www.ceimpact.com/podcast
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
